DNA Replication Licensing Protein MCM10 Promotes Tumor Progression and Is a Novel Prognostic Biomarker and Potential Therapeutic Target in Breast Cancer
Ravikiran Mahadevappa(University of Macau), Hang Fai Kwok(University of Macau)
Cited by 49
Related Papers
The prognostic significance of Cdc6 and Cdt1 in breast cancer
|Scientific Reports|2017|115
Over-Activation of Minichromosome Maintenance Protein 10 Promotes Genomic Instability in Early Stages of Breast Cancer
|International Journal of Biological Sciences|2022|10